While conducting the consensus study on a Framework for the Consideration of Chronic Debilitating Conditions in Women, three open meetings were held, two of which included sessions on the patient lived experience (May 31 and August 9, 2023). Given the breadth of chronic conditions covered in this study, it was not feasible to include patient perspectives representative of all conditions. The selection of those for the patient lived experience panels was therefore based on committee members’ requests to learn more about specific conditions: cardiovascular disease, migraine, endometriosis, and four autoimmune conditions – systemic lupus erythematosus, psoriasis, multiple sclerosis, and Sjogren’s syndrome.
Panelists representing either themselves or advocacy organizations for these chronic conditions were invited to share their experiences, struggles as they navigated the health care system, and reflections on how to improve facets of scientific research and clinical care – from diagnosis, treatment, and management. The committee and National Academies staff are grateful to Ann DeVelasco, Congresswoman Donna F. Edwards, Annika Ehrlich (Alliance for Headache Disorders Advocacy), Diana Falzone (Endometriosis Foundation), Evelyn Kelly, Ayesha Patrick (Autoimmune Association), and Wendy Rodgers (Lupus Foundation of America), for their participation and their invaluable contributions to the study.
Several themes common to the varied experiences of the panelists emerged during the panel sessions. When discussing the most significant barriers
they faced as patients/patient advocates, the most frequent responses were as follows:
The panelists suggested several ideas on how the health care system can improve to better serve patients. Next is a summary of their opinions, with selected quotations to provide context and better illustrate their positions:
“. . . I did some advocacy work in Washington, DC in reference to step therapy where you have to first try medications and then fail at them before you are given access to the medications that can actually help you . . . The amount of time that is taken that could have potentially benefitted a patient if they ha[d] gotten the right treatment, the access to the right treatment in the beginning, you lose that valuable time. Access is something that is hugely important.”
“If you do not have insurance, where do you go? Who do you go seek medical care for a disease that many times is invisible and not understood?”
“. . . a lot of the times in the clinical setting people do not ask you about any of your personal experience. You do not know that I am a mother and a grandmother, or you do not know that I am trying to go back to school. I will give a specific example. I decided to go back to school and do my second master’s. I started the first class,
and I could not retain anything. I happened to go into the neurologist for a follow-up appointment and I told him, what happened. He said . . . ‘I did not know that you were going back to school. The medication that you are taking causes that issue.’ He switched the medication. As soon as the medication was switched, I did beautifully.”
“. . . how important it is to listen to patients and to our experiences, because no two experiences are the same, but there are a lot of similarities when you live with a chronic illness.”
“I was sent to numerous specialists and my bloodwork always came back normal. And then I was told that it could be something psychosomatic . . .”
“If there are ways that different physicians can work together to create better systems to treat patients and of course uniquely, because everyone is different, I think that obviously would create a better outcome.”
“My saving grace has been connect[ing] with the autoimmune protocol community and changing my diet and working with functional medicine doctors, and naturopaths to assist me along my journey.”
“I truly believe we don’t have to be on this journey alone and really can have the information and resources we need to make informed decisions about our health.”
“. . . These stories . . . We all have one collected theme going on. Not being listened to enough, not being understood . . .”
“. . . really making sure that you have doctors who believe you, who listen to you. It is very important. It could be the difference between life and death because how one person is impacted might not be the same for another person. My story is not necessarily my friend’s story . . . But we all need customized care and that can be quite difficult navigating a health system.”
“. . . all of these things I think really resonate for all of us where you have a condition that is minimized or maybe not taken seriously.”
“. . . we need an increased awareness, and empathy, or acknowledgment that just because some symptoms cannot be explained by the traditional health care system, it doesn’t mean that you shouldn’t be taken seriously.”
“. . . there has to be more attention paid to awareness . . . in the medical community, and hospital emergency rooms . . . women talk so often of just being dismissed or diagnosed with GERD or something and not taken seriously that they may be having a heart attack”
One of the panelists who runs a cardiac rehabilitation program shared several comments about how gender and cultural norms influence the ways in which women seek care:
“. . . a lot of times the women are the last ones to call for help when they’re having chest pain. And whenever I get a new patient that comes to our group, a new Heart Sister who says, well, I didn’t really think it was important, I wasn’t going to call 911.”
“. . . a lot of times the woman only wants to present a position that she’s doing well rather than admitting to the things that are actually causing her a lot of difficulty. So, then the provider doesn’t really have the right picture to provide the right care.”
“Another thing that I see is that traditionally among our populations and even more among our Hispanic Heart Sisters, the women are not cultured to basically share their weaknesses, but they’re looked at more as the strength of the family. And they don’t like to change their role. . .”
The panelists also gave suggestions on aspects of research that could translate to better clinical outcomes relevant to specific chronic conditions:
“. . . in addition to the need to pursue better therapies, to make sure that we’re focused on research for chronic conditions that take all of us into consideration.”
Implementing plans that encourage patient engagement and patient-led approaches in research can improve both the patient experience and
actual health of these patients through open, active, reciprocated dialogue and education. This could lead to research efforts that are more focused on patients, as they will address questions that are most relevant and applicable to them. Conversely, involving patients allows them to contribute to the direction and prioritization of research. Patient partners in research could yield manifold benefits for both the research community and the patients themselves—patients can make better decisions, are more aware of health risks associated with treatments, and provide new perspectives that could spur research in new directions. An example involving patients as active partners in the research process is through collaborations with patient representatives and advocacy groups to create questionnaires that measure symptoms of particular chronic conditions. Other examples are engaging public attendees at conferences and receiving their feedback on health issues through surveys and other opportunities for public comment. Such findings may perhaps have better relevance and impact and inform the best ways to manage care and improve health outcomes.